A Randomized Controlled Trial on Safety of Steroid Avoidance in Immunologically Low-Risk Kidney Transplant Recipients

Awan, 2018, Trends in the causes of death among kidney transplant recipients in the United States (1996–2014), Am J Nephrol, 48, 472, 10.1159/000495081 Cosio, 2002, Patient survival after renal transplantation: IV. Impact of post-transplant diabetes, Kidney Int, 62, 1440, 10.1111/j.1523-1755.2002.kid582.x Hjelmesaeth, 2006, The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events, Kidney Int, 69, 588, 10.1038/sj.ki.5000116 Kasiske, 2003, Diabetes mellitus after kidney transplantation in the United States, Am J Transplant, 3, 178, 10.1034/j.1600-6143.2003.00010.x Valderhaug, 2011, The association of early post-transplant glucose levels with long-term mortality, Diabetologia, 54, 1341, 10.1007/s00125-011-2105-9 Valderhaug, 2009, Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation, Transplantation, 88, 429, 10.1097/TP.0b013e3181af1f53 First, 2013, New-onset diabetes after transplantation (NODAT): an evaluation of definitions in clinical trials, Transplantation, 96, 58, 10.1097/TP.0b013e318293fcf8 Ghisdal, 2012, New-onset diabetes after renal transplantation: risk assessment and management, Diabetes Care, 35, 181, 10.2337/dc11-1230 van Duijnhoven, 2003, Metabolic aspects of tacrolimus in renal transplantation. Consequences for the choice of an immunosuppressive regimen and for the management of post-transplant diabetes mellitus, Minerva Urol Nefrol, 55, 33 Haller, 2016, Steroid avoidance or withdrawal for kidney transplant recipients, Cochrane Database Syst Rev, 8 Ekberg, 2007, Reduced exposure to calcineurin inhibitors in renal transplantation, N Engl J Med, 357, 2562, 10.1056/NEJMoa067411 Thomusch, 2016, Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial [published correction appears in Lancet. 2017;389:804], Lancet, 388, 3006, 10.1016/S0140-6736(16)32187-0 Torres, 2018, Randomized controlled trial assessing the impact of tacrolimus versus cyclosporine on the incidence of posttransplant diabetes mellitus, Kidney Int Rep, 3, 1304, 10.1016/j.ekir.2018.07.009 Mourad, 2017, Incidence of posttransplantation diabetes mellitus in de novo kidney transplant recipients receiving prolonged-release tacrolimus-based immunosuppression with 2 different corticosteroid minimization strategies: ADVANCE, A randomized controlled trial, Transplantation, 101, 1924, 10.1097/TP.0000000000001453 Woodle, 2008, A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy, Ann Surg, 248, 564, 10.1097/SLA.0b013e318187d1da Brennan, 2006, Rabbit antithymocyte globulin versus basiliximab in renal transplantation, N Engl J Med, 355, 1967, 10.1056/NEJMoa060068 Ekberg, 2014, An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation, Transplant Res, 3, 12, 10.1186/2047-1440-3-12 van Gelder, 2008, Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial, Transplantation, 86, 1043, 10.1097/TP.0b013e318186f98a Roufosse, 2018, A 2018 reference guide to the Banff classification of renal allograft pathology [published correction appears in Transplantation. 2018;102:e497], Transplantation, 102, 1795, 10.1097/TP.0000000000002366 Woodle, 2020, Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: a prospective, randomized multicenter trial, Am J Transplant, 20, 1039, 10.1111/ajt.15688 Anglicheau, 2003, Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation, Nephrol Dial Transplant, 18, 2409, 10.1093/ndt/gfg381 Kagaya, 2008, No pharmacokinetic interactions between mycophenolic acid and tacrolimus in renal transplant recipients, J Clin Pharm Ther, 33, 193, 10.1111/j.1365-2710.2008.00906.x